BIOMARKERS FOR THE DIAGNOSIS, PROGNOSIS, ASSESSMENT AND THERAPY STRATIFICATION OF SYNCOPE
    7.
    发明公开
    BIOMARKERS FOR THE DIAGNOSIS, PROGNOSIS, ASSESSMENT AND THERAPY STRATIFICATION OF SYNCOPE 有权
    生物识别器ZUR THERAPEUTISCHEN SCHICHTUNG VON SYNKOPEN

    公开(公告)号:EP2841949A1

    公开(公告)日:2015-03-04

    申请号:EP13717432.2

    申请日:2013-04-12

    申请人: B.R.A.H.M.S GmbH

    IPC分类号: G01N33/68

    摘要: The present invention relates to a method for the diagnosis and/or prognosis and/or assessment and/or therapy stratification of syncope in a patient the method comprising: determining the level of at least one biomarker selected from the group consisting of proET-1, pro ADM, proANP, proBNP, proAVP and PCT or a fragment of at least 12 amino acids thereof, in a sample of a bodily fluid of said patient, correlating said level of at least one biomarker or fragments thereof with the diagnosis and/or prognosis and/or assessment and/or therapy stratification of syncope.

    摘要翻译: 本发明涉及一种用于诊断和/或预后和/或评估和/或治疗患者晕厥的治疗方法,所述方法包括:确定至少一种选自以下的生物标志物的水平:proADM,proANP, proBNP,proAVP,proET-1和PCT或其至少12个氨基酸的片段,在所述患者的体液样品中,将所述至少一种生物标志物或其片段的水平与诊断和/或预后相关联,以及 /或评估和/或治疗晕厥分层。